BU BÖLÜM HAKKINDA
Pulmonary fibrosis trials are advancing quickly, but many studies still struggle to enroll and complete on time. In this episode, Zach Gobst sits down with Dr. Aaron Milstone, a pulmonologist and principal investigator, to talk about what enrollment really looks like from the site side and what it takes to support patients through participation with dignity, clarity, and trust.
Dr. Milstone shares how pulmonary research has become increasingly competitive, why thoughtful pre-screening against inclusion/exclusion criteria protects both patients and study quality, and how practical logistics for patients, like travel and lodging support, can be the difference between someone being able to participate or not. The conversation highlights what happens when recruitment is treated as a partnership with sites and patients, not just a pipeline.
In this episode, we cover:
- Why pulmonary fibrosis trials are especially competitive for enrollment and what that means for sites and sponsors
- The role of careful pre-screening to ensure the right patients are approached for the right studies
- How travel and lodging support can reduce participation barriers without compromising trial rigor
- What builds (and erodes) trust for patients considering research participation
- Why enrollment success is essential to completing studies and generating evidence patients can rely on
Subscribe for more conversations on clinical research innovation that keeps patient needs at the center.
